#3855 Pregnancy outcomes in chronic hypertensive patients with superimposed preeclampsia: a nephrology outpatient experience

Abstract Background Chronic or pregestational hypertension affects 5%–10% of pregnancies and is associated with adverse maternal and neonatal events. Hypertension in pregnancy is associated with an increased risk of premature birth, low birth weight, and small-for-gestational-age newborns, especially due to a superimposed preeclampsia (PE). Up to 25% of women with chronic hypertension develop PE. Aims To evaluate pregnant women with chronic hypertension followed by a nephrology outpatient clinic and describe those who develop superimposed PE. Method Observational, descriptive, retrospective cohort study of 45 patients with chronic hypertension followed the nephrology hypertension-pregnancy clinic from 2017 to 2022. We analyzed the association between PE and clinical variables using Chi-square, Student's t-test, and ANOVA or their non-parametric equivalents. Results Mean age 36 years +/– 5.8. Caucasian race: 82% (n:37). Comorbidities: smokers (20%, n:9), type 2 Diabetes (8.9%, n:4), chronic hypothyroidism (8.9%, n:4), A family history of hypertension was present in 61.7% (n:21). Obstetric history revealed prior pregnancies in 68.9% (n:31), abortions (48.8%, n:22), and prior PE in 16.1% (n:5). Current pregnancy: first pregnancy (31.11%, n:14), multiple gestation (8.89%, n:4). Assisted reproduction (17.8%, n:8), Gestational diabetes (9.7% n:3). In the table, we compare patients with added PE versus those without it. 20 patients were previously receiving treatment, the most common therapies were ACE inhibitors (60%, n:12), ARBs (25%, n:5), Diuretics (10%, n:2), and B-Blockers (15%, n:1). In the third trimester, 20% (n:9) associated a second antihypertensive, the most used being Labetalol 11.1% (n:5) and 4.44% (n:2) received a third antihypertensive. Conclusion Maternal age, high BP in the first trimester, and the use of 2 or more antihypertensive drugs from the second trimester onwards are risk factors for superimposed PE in patients with chronic hypertension. Superimposed PE increases the risk of premature birth.

Authors

Institutions

Publication Details

Journal
Nephrology Dialysis Transplantation
Published
2025-10-01
DOI
https://doi.org/10.1093/ndt/gfaf116.1907
Primary Topic
Pregnancy and preeclampsia studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

#3855 Pregnancy outcomes in chronic hypertensive patients with superimposed preeclampsia: a nephrology outpatient experience

Yolanda Hernández Hernández, Yésika Amézquita, Antonio Cirugeda García, María Covadonga Hevia Ojanguren et al.
Nephrology Dialysis Transplantation
Pregnancy and preeclampsia studies
article

#3855 Pregnancy outcomes in chronic hypertensive patients with superimposed preeclampsia: a nephrology outpatient experience

Yolanda Hernández Hernández, Yésika Amézquita, Antonio Cirugeda García, María Covadonga Hevia Ojanguren, Gabriel Ledesma Sánchez, Rocío Echarri Carrillo, Raquel Díaz, Sílvia Caldés Ruisánchez, Gilda Carreño, A. Villalobos
article en

Abstract

Abstract Background Chronic or pregestational hypertension affects 5%–10% of pregnancies and is associated with adverse maternal and neonatal events. Hypertension in pregnancy is associated with an increased risk of premature birth, low birth weight, and small-for-gestational-age newborns, especially due to a superimposed preeclampsia (PE). Up to 25% of women with chronic hypertension develop PE. Aims To evaluate pregnant women with chronic hypertension followed by a nephrology outpatient clinic and describe those who develop superimposed PE. Method Observational, descriptive, retrospective cohort study of 45 patients with chronic hypertension followed the nephrology hypertension-pregnancy clinic from 2017 to 2022. We analyzed the association between PE and clinical variables using Chi-square, Student's t-test, and ANOVA or their non-parametric equivalents. Results Mean age 36 years +/– 5.8. Caucasian race: 82% (n:37). Comorbidities: smokers (20%, n:9), type 2 Diabetes (8.9%, n:4), chronic hypothyroidism (8.9%, n:4), A family history of hypertension was present in 61.7% (n:21). Obstetric history revealed prior pregnancies in 68.9% (n:31), abortions (48.8%, n:22), and prior PE in 16.1% (n:5). Current pregnancy: first pregnancy (31.11%, n:14), multiple gestation (8.89%, n:4). Assisted reproduction (17.8%, n:8), Gestational diabetes (9.7% n:3). In the table, we compare patients with added PE versus those without it. 20 patients were previously receiving treatment, the most common therapies were ACE inhibitors (60%, n:12), ARBs (25%, n:5), Diuretics (10%, n:2), and B-Blockers (15%, n:1). In the third trimester, 20% (n:9) associated a second antihypertensive, the most used being Labetalol 11.1% (n:5) and 4.44% (n:2) received a third antihypertensive. Conclusion Maternal age, high BP in the first trimester, and the use of 2 or more antihypertensive drugs from the second trimester onwards are risk factors for superimposed PE in patients with chronic hypertension. Superimposed PE increases the risk of premature birth.

Nephrology Dialysis TransplantationVol. 40(Supplement_3)
Hospital Universitario Infanta Sofía (ES)
Openalex Percentile: Top 62%
Pregnancy and preeclampsia studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.